ORIC Pharmaceuticals Overview
ORIC Pharmaceuticals Target Price
Analysts' 12-month price predictions for ORIC.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.02
Average Target Price
$18.33
128.6% upside
128.6% upside3 analysts in the last 4 months
High: $25 | Low: $15
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-15 | Goldman Sachs | $15 | 87% upside |  |
| 2026-02-24 | H.C. WainwrightRobert Burns | $25 | 211.7% upside | |
| 2026-02-24 | OppenheimerMatthew Biegler | $15 | 87% upside | |
| 2026-01-07 | Piper SandlerKelsey Goodwin | $22 | 174.3% upside | |
| 2025-12-08 | Wells Fargo | $25 | 211.7% upside | |
| 2025-11-14 | H.C. Wainwright | $23 | 186.8% upside | |
| 2025-09-04 | GuggenheimBrad Canino | $18 | 124.4% upside | |
| 2025-05-06 | OppenheimerMatthew Biegler | $12 | 49.6% upside | |
| 2024-09-05 | Stifel NicolausBradley Canino | $20 | 149.4% upside | |
| 2024-03-21 | H.C. WainwrightRobert Burns | $21 | 161.8% upside | |
| 2024-03-12 | WedbushDavid Nierengarten | $20 | 149.4% upside | |
| 2024-03-12 | OppenheimerMatthew Biegler | $17 | 112% upside | |
| 2022-04-05 | CitigroupYigel Nochomovitz | $7 |  12.7% downside | |